Research

Steve Fiering lab members

From Plant Virus to Cancer Vaccine

The idea of a vaccine for cancer is not new. But there are differences between human viruses and cancer that make creation of a cancer vaccine particularly challenging.

View story

Photo of project leads

Philanthropy-Backed Accelerator Advances Cancer Therapies

Three teams receive awards from the Dartmouth Innovations Accelerator for Cancer

View story

Mary Jo Turk, PhD

NH Cancer Researchers Find Cellular Evidence Behind Lasting Immune Response in Some Cancer Survivors

Researchers have found that a certain subpopulation of cells that enters a patient’s skin and blood during immunotherapy is behind the excellent and long-lasting immune responses to cancer that some survivors develop.

View story

Woman and child biking The Prouty

Where Do Prouty Donations Go? Winter 2021

Combining high-dose radiation therapy with immunotherapy to treat cancer, and resolving employment challenges among cancer survivors are among the newest research projects funded by The Prouty.

View story

Lesley Jarvis, MS, PhD and Brian Pogue, PhD

Seeing the Invisible: NCCC Pioneers Radiation Vision Cameras

Cherenkov imaging cameras invented by Dartmouth spinoff company and pioneered at NCCC allow radiation oncologists to visualize external beam field, improving quality, precision and patient safety during radiation therapy.

View story

immunologists in lab

Gifts Totaling $3.35 Million will Fuel Cancer Research in New Hampshire

A Dartmouth faculty member, a husband grateful for the care his wife received, and a Dartmouth College alumna and her husband have made gifts to accelerate immunotherapy research at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center.

View story

Prouty athletes

The Prouty Celebrates 40 Years

The 40th Annual Prouty launches fundraising campaign for 2021.

View story

FLASH beam

Piloting a FLASH Radiotherapy Beam for Treatment of Cancer

Researchers convert a standard linear accelerator used for radiation therapy, to deliver an ultra-high-dose rate beam to cancer patients “in a flash.”

View story

Diwakar Pattabiraman, PhD

Researchers Find Source of Breast Tumor Heterogeneity and Pathway that Limits Emergence

Researchers find a signaling pathway that limits mammary basal cells’ ability to fuel the growth of multiple aggressive cell populations within a breast tumor, uncovering opportunities for novel therapeutic approaches to breast cancer.

View story

Early-phase trials team

Clinical Trial of Anti-VISTA Cancer Antibody Therapy Opens for Patient Enrollment

Dartmouth-Hitchcock Norris Cotton Cancer Center leads a new multi-center Phase I in-human clinical trial of anti-VISTA, a therapeutic antibody designed to target a molecule that keeps the immune system quiet against cancer.

View story